BURDEN OF ILLNESS ASSOCIATED WITH MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

被引：0
|
作者：
Singh, M. [1 ]
Baculea, S. [1 ]
Quigley, J. M. [1 ]
Bergstrom, G. [2 ]
Holmgren, U. [2 ]
机构：
[1] ICON Clin Res UK Ltd, Abingdon, Oxon, England
[2] AstraZeneca, Molndal, Sweden
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.472
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS51
引用
收藏
页码：A118 / A119
页数：2
相关论文
共 50 条
  • [1] The burden of illness in patients with moderate to severe chronic obstructive pulmonary disease in Canada
    Maleki-Yazdi, M. Reza
    Kelly, Suzanne M.
    Lam, Sy S.
    Marin, Mihaela
    Barbeau, Martin
    Walker, Valery
    CANADIAN RESPIRATORY JOURNAL, 2012, 19 (05) : 319 - 324
  • [2] Differences in Symptom Burden Among Patients With Moderate, Severe, or Very Severe Chronic Obstructive Pulmonary Disease
    Christensen, Vivi Lycke
    Holm, Are Martin
    Cooper, Bruce
    Paul, Steven M.
    Miaskowski, Christine
    Rustoen, Tone
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2016, 51 (05) : 849 - 859
  • [3] PREVALENCE AND ASSOCIATED FACTORS OF EXERTIONAL DESATURATION IN MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Sathawarawong, W.
    Sirichana, W.
    RESPIROLOGY, 2016, 21 : 185 - 185
  • [4] Economic Burden of Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review
    de Nigris, E.
    Singh, B.
    Siddiqui, M.
    Holmgren, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Treatment options for moderate-to-very severe chronic obstructive pulmonary disease
    Cazzola, Mario
    Rogliani, Paola
    Ora, Josuel
    Matera, Maria Gabriella
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 977 - 988
  • [6] Ethics in moderate to severe chronic obstructive pulmonary disease
    Chalhoub, M
    Dernaika, T
    Imad, M
    CHEST, 2003, 124 (04) : 84S - 84S
  • [7] BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) HEALTHCARE COSTS IN PATIENTS WITH MODERATE-TO-SEVERE DISEASE
    Lubwama, R.
    Mayen, Herrera E.
    Petruski-Ivleva, N.
    Hawaldar, K.
    Madziva, D.
    Qureshi, T.
    Cheng, W. H.
    VALUE IN HEALTH, 2024, 27 (12) : S98 - S98
  • [8] Burden of Illness for an Employed Population with Chronic Obstructive Pulmonary Disease
    Nair, Kavita
    Ghushchyan, Vahram
    Van Den Bos, Jill
    Halford, Michael L.
    Tan, Gideon
    Frech-Tamas, Feride H.
    Doyle, Joseph
    POPULATION HEALTH MANAGEMENT, 2012, 15 (05) : 267 - 275
  • [9] Sleep quality and quality of life in patients with moderate to very severe chronic obstructive pulmonary disease
    Akinci, Buket
    Aslan, Goksen Kuran
    Kiyan, Esen
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (04): : 1739 - 1746
  • [10] Data on the safety and tolerability of revefenacin, in patients with moderate to very severe chronic obstructive pulmonary disease
    Donohue, James
    Kerwin, Edward
    Sethi, Sanjay
    Haumann, Brett
    Pendyala, Srikanth
    Dean, Lorna
    Barnes, Chris N.
    Moran, Edmund J.
    Crater, Glenn
    DATA IN BRIEF, 2019, 26
12345